Xilio Therapeutics (XLO) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-1.54
-1.05
-0.57
-0.08

Details

Expected EPS
-0.66
Actual EPS
N/A
Surprise EPS
0.66
Surprise Percent
+100%

Description

Xilio Therapeutics (XLO) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts